HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xu Xia Selected Research

epidermal growth factor receptor VIII

11/2011Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xu Xia Research Topics

Disease

3Neoplasms (Cancer)
10/2018 - 11/2011
3Breast Neoplasms (Breast Cancer)
10/2018 - 07/2017
2Rheumatoid Arthritis
11/2023 - 10/2023
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2023 - 10/2023
2Multiple Sclerosis
11/2023 - 10/2023
2Thyroid Neoplasms (Thyroid Cancer)
03/2021 - 01/2019
1Immune System Diseases (Immune Disorders)
04/2024
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2023
1COVID-19
11/2023
1Chronic Mucocutaneous Candidiasis
11/2023
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2023
1Dysbiosis
10/2023
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023
1Liver Diseases (Liver Disease)
10/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2023
1Dehydration (Water Stress)
02/2023
1Stroke (Strokes)
08/2018
1Infarction (Infarctions)
08/2018
1Brain Ischemia (Cerebral Ischemia)
08/2018
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2018
1Transient Ischemic Attack
08/2018
1Carcinogenesis
07/2017
1Hepatocellular Carcinoma (Hepatoma)
01/2016
1Liver Neoplasms (Liver Cancer)
01/2016
1Glioblastoma (Glioblastoma Multiforme)
11/2011
1Glioma (Gliomas)
11/2011

Drug/Important Bio-Agent (IBA)

3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2023 - 01/2019
3ErbB Receptors (EGF Receptor)IBA
10/2018 - 11/2011
2CytokinesIBA
04/2024 - 11/2023
2DiterpenesIBA
03/2021 - 01/2019
2Mitogen-Activated Protein KinasesIBA
03/2021 - 01/2019
2ferruginolIBA
03/2021 - 01/2019
2Estrogen ReceptorsIBA
10/2018 - 01/2018
2Progesterone Receptors (Progesterone Receptor)IBA
10/2018 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 01/2018
2ParaffinIBA
10/2018 - 01/2018
2Epidermal Growth Factor (EGF)IBA
10/2018 - 01/2018
2Cadherins (E-Cadherin)IBA
10/2018 - 01/2018
2Indicators and Reagents (Reagents)IBA
07/2017 - 01/2016
1Rituximab (Mabthera)FDA Link
11/2023
1AutoantibodiesIBA
11/2023
1Antiphospholipid AntibodiesIBA
11/2023
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2023
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
11/2023
1Volatile Fatty AcidsIBA
10/2023
1PolyphenolsIBA
08/2023
1Therapeutic UsesIBA
08/2023
1LigninIBA
02/2023
1CelluloseIBA
02/2023
1Polyvinyl Chloride (PVC)IBA
02/2023
1Hydroxyl RadicalIBA
02/2023
1ningdongIBA
03/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Eosine Yellowish-(YS) (Eosin)IBA
10/2018
1Hematoxylin (Haematoxylon)IBA
10/2018
1Coloring Agents (Dyes)IBA
10/2018
1Phytoestrogens (Phytoestrogen)IBA
08/2018
1GenisteinIBA
08/2018
1triphenyltetrazoliumIBA
08/2018
1Neuroprotective AgentsIBA
08/2018
1EnzymesIBA
07/2017
1Deubiquitinating EnzymesIBA
07/2017
1DYC-279IBA
01/2016
1cediranib (AZD2171)IBA
11/2011
1epidermal growth factor receptor VIIIIBA
11/2011
1Temozolomide (Temodar)FDA LinkGeneric
11/2011

Therapy/Procedure

1Fecal Microbiota Transplantation
10/2023
1Drug Therapy (Chemotherapy)
01/2019
1Estrogen Replacement Therapy
08/2018